Side-by-side comparison of AI visibility scores, market position, and capabilities
Bengaluru/Boston robotic digital pathology with RoboTome (2x sectioning speed) and MorphoLens (100+ slides/hour); $5M Series A Nov 2025 Inflexor Ventures with 80+ patents and US/European lab deployments competing with Leica for histopathology automation.
Morphle Labs is a Bengaluru, India and Boston, Massachusetts-based robotic microscopy and digital pathology company — raising $5 million in Series A funding in November 2025 led by Inflexor Ventures — providing histopathology laboratories with AI-powered physical automation platforms that address the speed and throughput bottlenecks in cancer diagnostics workflows. With 80+ patents filed and products deployed in leading US and European laboratories, Morphle's 100-member team has developed two flagship platforms: RoboTome (a robotic microtome system that slices biopsy tissue blocks at 2x the speed of experienced histotechnologists) and MorphoLens (a high-throughput slide scanner that digitizes 100+ histology slides per hour for digital pathology review). Founded to "revolutionize cancer diagnostics with physical AI," Morphle expands manufacturing, regulatory clearances, and global presence with the Series A.
Bucket Robotics builds modular autonomous mobile robots for warehouse and industrial environments, designed for rapid deployment without requiring fixed infrastructure or facility modifications.
Bucket Robotics is an autonomous mobile robot (AMR) company that designs modular, rapidly deployable robots for warehouse automation and industrial material handling. Unlike traditional warehouse automation systems that require significant facility modifications, fixed conveyors, and multi-month installation projects, Bucket Robotics' AMRs navigate dynamically using onboard sensors and AI, allowing deployment in existing facilities without permanent infrastructure changes.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.